| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.55e-11 | 130 | 37 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | GTP binding | 5.30e-07 | 397 | 37 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.13e-06 | 439 | 37 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.13e-06 | 439 | 37 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | structural molecule activity | TUBA1B GPM6B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 2.71e-05 | 891 | 37 | 9 | GO:0005198 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | OBSL1 TUBA1B TUBA3E SIK3 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 3.74e-07 | 720 | 37 | 10 | GO:0000226 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | OBSL1 PPP2R3B TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C PML | 1.01e-06 | 1014 | 37 | 11 | GO:0000278 |
| GeneOntologyBiologicalProcess | microtubule-based process | OBSL1 TUBA1B TUBA3E SIK3 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 1.18e-05 | 1058 | 37 | 10 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of Toll signaling pathway | 4.68e-05 | 6 | 37 | 2 | GO:0008592 | |
| GeneOntologyCellularComponent | microtubule | 5.20e-06 | 533 | 39 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 2.13e-04 | 899 | 39 | 8 | GO:0099513 | |
| GeneOntologyCellularComponent | supramolecular fiber | OBSL1 TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 2.55e-04 | 1179 | 39 | 9 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | OBSL1 TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 2.68e-04 | 1187 | 39 | 9 | GO:0099081 |
| Domain | Alpha_tubulin | 2.35e-18 | 9 | 37 | 7 | IPR002452 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.09e-14 | 22 | 37 | 7 | IPR018316 | |
| Domain | Tubulin_C | 1.09e-14 | 22 | 37 | 7 | SM00865 | |
| Domain | Tubulin_C | 1.09e-14 | 22 | 37 | 7 | PF03953 | |
| Domain | Tubulin_C | 1.57e-14 | 23 | 37 | 7 | IPR023123 | |
| Domain | TUBULIN | 1.57e-14 | 23 | 37 | 7 | PS00227 | |
| Domain | Tubulin | 1.57e-14 | 23 | 37 | 7 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.57e-14 | 23 | 37 | 7 | IPR008280 | |
| Domain | Tubulin | 1.57e-14 | 23 | 37 | 7 | SM00864 | |
| Domain | Tubulin_CS | 1.57e-14 | 23 | 37 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.21e-14 | 24 | 37 | 7 | IPR003008 | |
| Domain | Tubulin | 2.21e-14 | 24 | 37 | 7 | PF00091 | |
| Domain | - | 1.50e-12 | 20 | 37 | 6 | 3.30.1330.20 | |
| Domain | - | 2.10e-12 | 21 | 37 | 6 | 1.10.287.600 | |
| Domain | - | 2.88e-12 | 22 | 37 | 6 | 3.40.50.1440 | |
| Domain | Pellino | 1.14e-05 | 3 | 37 | 2 | PF04710 | |
| Domain | Pellino_fam | 1.14e-05 | 3 | 37 | 2 | IPR006800 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.90e-18 | 17 | 31 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.81e-18 | 18 | 31 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.52e-17 | 19 | 31 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.52e-17 | 19 | 31 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.53e-17 | 20 | 31 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.53e-17 | 20 | 31 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.08e-17 | 21 | 31 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.08e-17 | 21 | 31 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 6.40e-17 | 22 | 31 | 8 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 9.80e-17 | 23 | 31 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 9.80e-17 | 23 | 31 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 9.80e-17 | 23 | 31 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.47e-16 | 24 | 31 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.47e-16 | 24 | 31 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.16e-16 | 25 | 31 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.16e-16 | 25 | 31 | 8 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.11e-16 | 26 | 31 | 8 | M47672 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 3.11e-16 | 26 | 31 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 6.17e-16 | 28 | 31 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 8.51e-16 | 29 | 31 | 8 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.08e-15 | 32 | 31 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.08e-15 | 32 | 31 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.74e-15 | 33 | 31 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.74e-15 | 33 | 31 | 8 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.62e-15 | 35 | 31 | 8 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.57e-15 | 38 | 31 | 8 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.82e-14 | 43 | 31 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.82e-14 | 43 | 31 | 8 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 3.44e-14 | 44 | 31 | 8 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.44e-14 | 44 | 31 | 8 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 4.17e-14 | 45 | 31 | 8 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 5.05e-14 | 46 | 31 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.68e-14 | 49 | 31 | 8 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.22e-13 | 51 | 31 | 8 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.70e-13 | 53 | 31 | 8 | M27651 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.32e-13 | 55 | 31 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.71e-13 | 56 | 31 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.14e-13 | 57 | 31 | 8 | M27251 | |
| Pathway | REACTOME_KINESINS | 5.57e-13 | 61 | 31 | 8 | M977 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 8.23e-13 | 17 | 31 | 6 | MM14731 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.98e-12 | 71 | 31 | 8 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 2.23e-12 | 72 | 31 | 8 | M26954 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA1B TUBA3E ITGA5 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 3.22e-12 | 121 | 31 | 9 | M872 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.49e-12 | 76 | 31 | 8 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.49e-12 | 76 | 31 | 8 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.81e-12 | 79 | 31 | 8 | M27743 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.07e-11 | 138 | 31 | 9 | M29805 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.41e-11 | 90 | 31 | 8 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 1.41e-11 | 90 | 31 | 8 | M4013 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.94e-11 | 27 | 31 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.94e-11 | 27 | 31 | 6 | MM15674 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.01e-11 | 94 | 31 | 8 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.19e-11 | 95 | 31 | 8 | M6729 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.82e-11 | 98 | 31 | 8 | M776 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.10e-11 | 29 | 31 | 6 | MM15219 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.33e-11 | 100 | 31 | 8 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 3.91e-11 | 102 | 31 | 8 | M27648 | |
| Pathway | REACTOME_HCMV_INFECTION | 4.54e-11 | 162 | 31 | 9 | M29804 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.89e-11 | 32 | 31 | 6 | MM14730 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.06e-10 | 68 | 31 | 7 | MM14968 | |
| Pathway | REACTOME_AGGREPHAGY | 1.26e-10 | 36 | 31 | 6 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.50e-10 | 37 | 31 | 6 | MM15102 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.16e-10 | 126 | 31 | 8 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.30e-10 | 127 | 31 | 8 | M27181 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | PPP2R3B TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 2.99e-10 | 200 | 31 | 9 | M864 |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 3.54e-10 | 134 | 31 | 8 | M27751 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.50e-10 | 44 | 31 | 6 | MM14606 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.03e-10 | 140 | 31 | 8 | M27550 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 5.55e-10 | 20 | 31 | 5 | MM1383 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.78e-10 | 48 | 31 | 6 | MM15353 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 9.21e-10 | 151 | 31 | 8 | M550 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.19e-09 | 156 | 31 | 8 | M27097 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.28e-09 | 52 | 31 | 6 | MM14949 | |
| Pathway | REACTOME_AUTOPHAGY | 1.32e-09 | 158 | 31 | 8 | M27935 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.62e-09 | 54 | 31 | 6 | M27482 | |
| Pathway | REACTOME_KINESINS | 2.27e-09 | 57 | 31 | 6 | MM15714 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.36e-09 | 170 | 31 | 8 | M941 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.66e-09 | 273 | 31 | 9 | M983 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 5.02e-09 | 187 | 31 | 8 | M961 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 5.61e-09 | 66 | 31 | 6 | MM17074 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 5.93e-09 | 191 | 31 | 8 | M29614 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 6.73e-09 | 68 | 31 | 6 | MM14921 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 8.85e-09 | 201 | 31 | 8 | M27472 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 9.56e-09 | 203 | 31 | 8 | M27654 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 9.94e-09 | 204 | 31 | 8 | M4217 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.03e-08 | 205 | 31 | 8 | M752 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.04e-08 | 73 | 31 | 6 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.04e-08 | 73 | 31 | 6 | MM15672 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.10e-08 | 236 | 31 | 8 | M27185 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.70e-08 | 90 | 31 | 6 | MM14979 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.81e-08 | 94 | 31 | 6 | MM14515 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.19e-08 | 98 | 31 | 6 | MM15352 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 6.77e-08 | 261 | 31 | 8 | M42565 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 8.79e-08 | 270 | 31 | 8 | M15514 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 8.86e-08 | 52 | 31 | 5 | MM15211 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.16e-07 | 184 | 31 | 7 | MM15145 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.24e-07 | 110 | 31 | 6 | MM15350 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 1.45e-07 | 113 | 31 | 6 | M27471 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.70e-07 | 116 | 31 | 6 | MM14855 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.70e-07 | 116 | 31 | 6 | MM15715 | |
| Pubmed | 1.04e-23 | 9 | 39 | 8 | 21167302 | ||
| Pubmed | 8.69e-20 | 19 | 39 | 8 | 15691386 | ||
| Pubmed | 8.69e-20 | 19 | 39 | 8 | 15698476 | ||
| Pubmed | 3.67e-19 | 22 | 39 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 3.71e-17 | 8 | 39 | 6 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 2.12e-16 | 22 | 39 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.22e-15 | 12 | 39 | 6 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 2.27e-15 | 13 | 39 | 6 | 10908577 | |
| Pubmed | 3.96e-15 | 14 | 39 | 6 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 8.14e-15 | 6 | 39 | 5 | 7651436 | |
| Pubmed | 8.14e-15 | 6 | 39 | 5 | 16327313 | ||
| Pubmed | 8.14e-15 | 6 | 39 | 5 | 3785200 | ||
| Pubmed | 2.85e-14 | 7 | 39 | 5 | 11146551 | ||
| Pubmed | 9.78e-14 | 22 | 39 | 6 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 1.71e-13 | 9 | 39 | 5 | 11953448 | |
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 18400243 | ||
| Pubmed | 8.32e-12 | 17 | 39 | 5 | 17360745 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 36681692 | ||
| Pubmed | 8.73e-11 | 212 | 39 | 8 | 23463506 | ||
| Pubmed | 1.01e-09 | 94 | 39 | 6 | 36584595 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.30e-09 | 3 | 39 | 3 | 9722999 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 11163133 | ||
| Pubmed | 8.45e-09 | 239 | 39 | 7 | 23246001 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10840040 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 18613978 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 12090300 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 3.04e-08 | 288 | 39 | 7 | 31501420 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 8.55e-08 | 98 | 39 | 5 | 21942715 | |
| Pubmed | 8.74e-08 | 513 | 39 | 8 | 25798074 | ||
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 19103752 | ||
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 2.14e-07 | 11 | 39 | 3 | 20405035 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 2.89e-07 | 125 | 39 | 5 | 36030824 | |
| Pubmed | 2.99e-07 | 50 | 39 | 4 | 23703321 | ||
| Pubmed | 3.70e-07 | 13 | 39 | 3 | 14697242 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.57e-07 | 271 | 39 | 6 | 32433965 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 1.23e-06 | 2 | 39 | 2 | 3839072 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22296162 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25328666 | ||
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 1.23e-06 | 2 | 39 | 2 | 24268707 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12054644 | ||
| Pubmed | 1.71e-06 | 21 | 39 | 3 | 36332009 | ||
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 1.98e-06 | 22 | 39 | 3 | 30446499 | |
| Pubmed | 3.39e-06 | 206 | 39 | 5 | 22174317 | ||
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 3.67e-06 | 3 | 39 | 2 | 12749852 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31767681 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12087096 | ||
| Pubmed | Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions. | 3.67e-06 | 3 | 39 | 2 | 6646120 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 8566014 | ||
| Pubmed | The role of Tuba1a in adult hippocampal neurogenesis and the formation of the dentate gyrus. | 3.67e-06 | 3 | 39 | 2 | 21041996 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9885248 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 19409876 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11082048 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 3.99e-06 | 95 | 39 | 4 | 27129302 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12024216 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 28555754 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 9372968 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16884718 | ||
| Pubmed | Pellino proteins contain a cryptic FHA domain that mediates interaction with phosphorylated IRAK1. | 7.34e-06 | 4 | 39 | 2 | 19081057 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17389232 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 8.83e-06 | 116 | 39 | 4 | 22810585 | |
| Pubmed | 9.86e-06 | 37 | 39 | 3 | 9798653 | ||
| Pubmed | Tuba8 is expressed at low levels in the developing mouse and human brain. | 1.22e-05 | 5 | 39 | 2 | 20466094 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 11826099 | ||
| Pubmed | HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. | 1.22e-05 | 5 | 39 | 2 | 12606581 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 23042151 | ||
| Pubmed | Prefoldin recognition motifs in the nonhomologous proteins of the actin and tubulin families. | 1.22e-05 | 5 | 39 | 2 | 11535601 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 28388629 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 15129282 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 1.22e-05 | 5 | 39 | 2 | 3839797 | |
| Pubmed | Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. | 1.83e-05 | 6 | 39 | 2 | 12716939 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 15916950 | ||
| Pubmed | Microtubule binding proteins CLIP-170, EB1, and p150Glued form distinct plus-end complexes. | 1.83e-05 | 6 | 39 | 2 | 16455083 | |
| Pubmed | Analysis of estrogen receptor alpha signaling complex at the plasma membrane. | 1.83e-05 | 6 | 39 | 2 | 15556606 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 25027698 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 7744867 | ||
| Pubmed | The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability. | 1.83e-05 | 6 | 39 | 2 | 12639963 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 8530437 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 37011206 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17675297 | ||
| Pubmed | 2.19e-05 | 146 | 39 | 4 | 21589869 | ||
| Pubmed | Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex. | 2.56e-05 | 7 | 39 | 2 | 10191277 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 16261417 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 27010057 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 2.72e-05 | 317 | 39 | 5 | 17620599 | |
| Pubmed | 2.93e-05 | 322 | 39 | 5 | 26514267 | ||
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 3.11e-05 | 54 | 39 | 3 | 21525035 | |
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 20409569 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 14583623 | ||
| Pubmed | Pellino3 is a novel upstream regulator of p38 MAPK and activates CREB in a p38-dependent manner. | 3.42e-05 | 8 | 39 | 2 | 15917247 | |
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 16039987 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 11698390 | ||
| Pubmed | 3.85e-05 | 58 | 39 | 3 | 27869233 | ||
| Pubmed | 4.85e-05 | 878 | 39 | 7 | 37223481 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 20797700 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 11964161 | ||
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 29162887 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 11532003 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 7.32e-05 | 639 | 39 | 6 | 23443559 | |
| Pubmed | Selective contribution of eukaryotic prefoldin subunits to actin and tubulin binding. | 8.03e-05 | 12 | 39 | 2 | 14634002 | |
| Interaction | TCP11L2 interactions | 6.55e-15 | 21 | 39 | 7 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 2.37e-10 | 19 | 39 | 5 | int:GRM7 | |
| Interaction | CD81 interactions | TUBA1B TUBA3E ITGA5 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 4.97e-09 | 303 | 39 | 9 | int:CD81 |
| Interaction | TTC5 interactions | 1.58e-07 | 65 | 39 | 5 | int:TTC5 | |
| Interaction | LTA interactions | 2.37e-07 | 28 | 39 | 4 | int:LTA | |
| Interaction | SLURP1 interactions | 3.22e-07 | 144 | 39 | 6 | int:SLURP1 | |
| Interaction | IL12RB1 interactions | 6.85e-07 | 87 | 39 | 5 | int:IL12RB1 | |
| Interaction | SERPINB11 interactions | 1.09e-06 | 11 | 39 | 3 | int:SERPINB11 | |
| Interaction | TFCP2 interactions | 1.54e-06 | 436 | 39 | 8 | int:TFCP2 | |
| Interaction | ITGAD interactions | 1.84e-06 | 46 | 39 | 4 | int:ITGAD | |
| Interaction | TUBB2B interactions | 2.54e-06 | 205 | 39 | 6 | int:TUBB2B | |
| Interaction | CAPSL interactions | 3.00e-06 | 15 | 39 | 3 | int:CAPSL | |
| Interaction | CCT2 interactions | 3.88e-06 | 666 | 39 | 9 | int:CCT2 | |
| Interaction | TXNDC9 interactions | 3.96e-06 | 124 | 39 | 5 | int:TXNDC9 | |
| Interaction | SIAH1 interactions | 4.13e-06 | 223 | 39 | 6 | int:SIAH1 | |
| Interaction | UBL4A interactions | 4.20e-06 | 349 | 39 | 7 | int:UBL4A | |
| Interaction | LYPD1 interactions | 4.71e-06 | 58 | 39 | 4 | int:LYPD1 | |
| Interaction | PAK1 interactions | 4.81e-06 | 229 | 39 | 6 | int:PAK1 | |
| Interaction | ZC2HC1A interactions | 7.00e-06 | 64 | 39 | 4 | int:ZC2HC1A | |
| Interaction | IRAK2 interactions | 7.92e-06 | 66 | 39 | 4 | int:IRAK2 | |
| Interaction | CDHR4 interactions | 8.92e-06 | 68 | 39 | 4 | int:CDHR4 | |
| Interaction | GABRA1 interactions | 1.07e-05 | 152 | 39 | 5 | int:GABRA1 | |
| Interaction | ADAMTS4 interactions | 1.12e-05 | 72 | 39 | 4 | int:ADAMTS4 | |
| Interaction | NEK4 interactions | 1.29e-05 | 582 | 39 | 8 | int:NEK4 | |
| Interaction | BRINP3 interactions | 1.50e-05 | 25 | 39 | 3 | int:BRINP3 | |
| Interaction | CAPS interactions | 1.50e-05 | 25 | 39 | 3 | int:CAPS | |
| Interaction | CCT3 interactions | 1.68e-05 | 604 | 39 | 8 | int:CCT3 | |
| Interaction | BACE2 interactions | 1.88e-05 | 82 | 39 | 4 | int:BACE2 | |
| Interaction | ZC2HC1B interactions | 2.12e-05 | 28 | 39 | 3 | int:ZC2HC1B | |
| Interaction | BSG interactions | 2.30e-05 | 631 | 39 | 8 | int:BSG | |
| Interaction | TNPO1 interactions | 2.50e-05 | 306 | 39 | 6 | int:TNPO1 | |
| Interaction | PRTN3 interactions | 2.84e-05 | 91 | 39 | 4 | int:PRTN3 | |
| Interaction | TSHR interactions | 3.50e-05 | 96 | 39 | 4 | int:TSHR | |
| Interaction | TES interactions | 3.94e-05 | 332 | 39 | 6 | int:TES | |
| Interaction | KLK11 interactions | 4.58e-05 | 36 | 39 | 3 | int:KLK11 | |
| Interaction | CCT6B interactions | 4.72e-05 | 207 | 39 | 5 | int:CCT6B | |
| Interaction | LOXL4 interactions | 4.79e-05 | 104 | 39 | 4 | int:LOXL4 | |
| Interaction | EDN3 interactions | 5.55e-05 | 108 | 39 | 4 | int:EDN3 | |
| Interaction | GTSE1 interactions | 5.65e-05 | 215 | 39 | 5 | int:GTSE1 | |
| Interaction | INSYN2A interactions | 5.84e-05 | 39 | 39 | 3 | int:INSYN2A | |
| Interaction | CD48 interactions | 5.84e-05 | 39 | 39 | 3 | int:CD48 | |
| Interaction | ALDH3B1 interactions | 6.18e-05 | 111 | 39 | 4 | int:ALDH3B1 | |
| Interaction | NUP210P1 interactions | 7.30e-05 | 42 | 39 | 3 | int:NUP210P1 | |
| Interaction | VAV1 interactions | 7.46e-05 | 228 | 39 | 5 | int:VAV1 | |
| Interaction | CCT8 interactions | 7.82e-05 | 550 | 39 | 7 | int:CCT8 | |
| Interaction | TUBB4B interactions | 8.75e-05 | 560 | 39 | 7 | int:TUBB4B | |
| Interaction | TCP1 interactions | 8.85e-05 | 561 | 39 | 7 | int:TCP1 | |
| Interaction | PRSS50 interactions | 9.60e-05 | 46 | 39 | 3 | int:PRSS50 | |
| Interaction | SSR2 interactions | 9.60e-05 | 46 | 39 | 3 | int:SSR2 | |
| Interaction | CCT6A interactions | 9.77e-05 | 570 | 39 | 7 | int:CCT6A | |
| Interaction | PFDN4 interactions | 9.81e-05 | 125 | 39 | 4 | int:PFDN4 | |
| Interaction | TUBB6 interactions | 1.01e-04 | 243 | 39 | 5 | int:TUBB6 | |
| Interaction | DHDH interactions | 1.02e-04 | 47 | 39 | 3 | int:DHDH | |
| Interaction | NLRP1 interactions | 1.02e-04 | 47 | 39 | 3 | int:NLRP1 | |
| Interaction | CCT7 interactions | 1.03e-04 | 575 | 39 | 7 | int:CCT7 | |
| Interaction | TRAV20 interactions | 1.09e-04 | 48 | 39 | 3 | int:TRAV20 | |
| Interaction | TMPRSS5 interactions | 1.09e-04 | 48 | 39 | 3 | int:TMPRSS5 | |
| Interaction | TUBA3C interactions | 1.11e-04 | 129 | 39 | 4 | int:TUBA3C | |
| Interaction | PLA2G7 interactions | 1.30e-04 | 9 | 39 | 2 | int:PLA2G7 | |
| Interaction | LGALS7 interactions | 1.48e-04 | 139 | 39 | 4 | int:LGALS7 | |
| Interaction | HEY1 interactions | 1.52e-04 | 140 | 39 | 4 | int:HEY1 | |
| Interaction | PFN3 interactions | 1.63e-04 | 10 | 39 | 2 | int:PFN3 | |
| Interaction | NXPH3 interactions | 1.92e-04 | 58 | 39 | 3 | int:NXPH3 | |
| Interaction | INSL5 interactions | 1.92e-04 | 58 | 39 | 3 | int:INSL5 | |
| Interaction | GRAMD2A interactions | 1.99e-04 | 11 | 39 | 2 | int:GRAMD2A | |
| Interaction | MEPCE interactions | 2.00e-04 | 859 | 39 | 8 | int:MEPCE | |
| Interaction | NSUN5P1 interactions | 2.02e-04 | 59 | 39 | 3 | int:NSUN5P1 | |
| Interaction | KLK15 interactions | 2.03e-04 | 151 | 39 | 4 | int:KLK15 | |
| Interaction | LGALS3BP interactions | 2.16e-04 | 286 | 39 | 5 | int:LGALS3BP | |
| Interaction | ITLN1 interactions | 2.23e-04 | 61 | 39 | 3 | int:ITLN1 | |
| Interaction | LGALS2 interactions | 2.38e-04 | 12 | 39 | 2 | int:LGALS2 | |
| Interaction | SKI interactions | 2.53e-04 | 160 | 39 | 4 | int:SKI | |
| Interaction | ACOT8 interactions | 2.69e-04 | 65 | 39 | 3 | int:ACOT8 | |
| Interaction | TUBA1C interactions | 2.90e-04 | 478 | 39 | 6 | int:TUBA1C | |
| Interaction | SNX21 interactions | 2.95e-04 | 67 | 39 | 3 | int:SNX21 | |
| Interaction | STARD13 interactions | 3.08e-04 | 68 | 39 | 3 | int:STARD13 | |
| Interaction | TSPYL6 interactions | 3.08e-04 | 68 | 39 | 3 | int:TSPYL6 | |
| Interaction | PFDN6 interactions | 3.12e-04 | 169 | 39 | 4 | int:PFDN6 | |
| Interaction | ADARB1 interactions | 3.27e-04 | 489 | 39 | 6 | int:ADARB1 | |
| Interaction | BAGE2 interactions | 3.35e-04 | 70 | 39 | 3 | int:BAGE2 | |
| Interaction | PFDN5 interactions | 3.36e-04 | 315 | 39 | 5 | int:PFDN5 | |
| Interaction | TUBB2A interactions | 3.41e-04 | 316 | 39 | 5 | int:TUBB2A | |
| Interaction | TUBA1B interactions | 3.61e-04 | 498 | 39 | 6 | int:TUBA1B | |
| Interaction | MTMR2 interactions | 3.64e-04 | 72 | 39 | 3 | int:MTMR2 | |
| Interaction | CHKA interactions | 3.77e-04 | 15 | 39 | 2 | int:CHKA | |
| Interaction | TRAC interactions | 3.77e-04 | 15 | 39 | 2 | int:TRAC | |
| Interaction | GZMH interactions | 3.95e-04 | 74 | 39 | 3 | int:GZMH | |
| Interaction | CST11 interactions | 4.11e-04 | 75 | 39 | 3 | int:CST11 | |
| Interaction | TCP11L1 interactions | 4.11e-04 | 75 | 39 | 3 | int:TCP11L1 | |
| Interaction | FAM187B interactions | 4.30e-04 | 16 | 39 | 2 | int:FAM187B | |
| Interaction | LRRC25 interactions | 4.40e-04 | 185 | 39 | 4 | int:LRRC25 | |
| Interaction | F12 interactions | 4.44e-04 | 77 | 39 | 3 | int:F12 | |
| Interaction | MAGT1 interactions | 4.49e-04 | 186 | 39 | 4 | int:MAGT1 | |
| Interaction | CCT5 interactions | 4.77e-04 | 525 | 39 | 6 | int:CCT5 | |
| Interaction | ATOH1 interactions | 4.97e-04 | 80 | 39 | 3 | int:ATOH1 | |
| Interaction | OSTM1 interactions | 4.97e-04 | 80 | 39 | 3 | int:OSTM1 | |
| Interaction | LRP1 interactions | 5.47e-04 | 196 | 39 | 4 | int:LRP1 | |
| Interaction | TPSB2 interactions | 5.47e-04 | 18 | 39 | 2 | int:TPSB2 | |
| Interaction | GLMP interactions | 5.73e-04 | 84 | 39 | 3 | int:GLMP | |
| Interaction | TMEM263 interactions | 5.93e-04 | 85 | 39 | 3 | int:TMEM263 | |
| Cytoband | 12q13.12 | 4.68e-06 | 38 | 39 | 3 | 12q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.53e-04 | 423 | 39 | 4 | chr12q13 | |
| Cytoband | 2q21.1 | 1.13e-03 | 58 | 39 | 2 | 2q21.1 | |
| Cytoband | 2q35 | 2.08e-03 | 79 | 39 | 2 | 2q35 | |
| GeneFamily | Tubulins | 1.69e-17 | 26 | 28 | 8 | 778 | |
| GeneFamily | Pellino E3 ubiquitin protein ligases | 6.93e-06 | 3 | 28 | 2 | 676 | |
| Coexpression | TOMIDA_METASTASIS_UP | 7.73e-06 | 26 | 39 | 3 | M17830 | |
| Coexpression | ALONSO_METASTASIS_UP | 9.90e-06 | 194 | 39 | 5 | M3582 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 1.61e-05 | 33 | 39 | 3 | M7409 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 1.77e-05 | 34 | 39 | 3 | M14043 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 1.93e-05 | 35 | 39 | 3 | M8191 | |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP | 5.86e-05 | 142 | 39 | 4 | M7971 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 6.14e-05 | 284 | 39 | 5 | M16975 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 7.17e-05 | 54 | 39 | 3 | M1349 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | 8.03e-05 | 154 | 39 | 4 | M3766 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-07 | 190 | 39 | 5 | 638bebe200249ff6f7be764d89bd762da39ebaae | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 170 | 39 | 4 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 2.03e-05 | 185 | 39 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 188 | 39 | 4 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 189 | 39 | 4 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.26e-05 | 190 | 39 | 4 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|(1)_Control_(PBS) / Stress and Cell class | 2.35e-05 | 192 | 39 | 4 | 40f380f5f0bed63a7404be050838ebd01ef08987 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 2.40e-05 | 193 | 39 | 4 | f31398dad5321a7bcb27e208bd73630e9756e897 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 2.40e-05 | 193 | 39 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 2.55e-05 | 196 | 39 | 4 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-05 | 199 | 39 | 4 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 133 | 39 | 3 | bc29a2faa151b0e48c1c7e3f016cccc49f9a15eb | |
| ToppCell | COVID-19_Mild-PLT_3|World / Disease Group and Platelet Clusters | 2.86e-04 | 147 | 39 | 3 | 9d3271aa735ddb6f32ab864d7afcfb0f8754383b | |
| ToppCell | COVID-Treg|COVID / Condition, Cell_class and T cell subcluster | 3.41e-04 | 156 | 39 | 3 | a1dd61d4c9ed8f283f0fcbf875c5fd7807ca370d | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 157 | 39 | 3 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.60e-04 | 159 | 39 | 3 | f376bf6cd0ed374211edac3c384f3a78f0caef2a | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 160 | 39 | 3 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 160 | 39 | 3 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.95e-04 | 164 | 39 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-04 | 166 | 39 | 3 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.23e-04 | 168 | 39 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 4.31e-04 | 169 | 39 | 3 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-04 | 170 | 39 | 3 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.46e-04 | 171 | 39 | 3 | 7b0783d25055e5ea5b2fc44ebcb16bfd0adbcf81 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 4.53e-04 | 172 | 39 | 3 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 4.53e-04 | 172 | 39 | 3 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 4f849d236ee358ad30ac977745ac43c8e9778e94 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 39c3b8313354c4c60764597507a2505dcfa4e8c7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-04 | 37 | 39 | 2 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 177 | 39 | 3 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.01e-04 | 178 | 39 | 3 | cb9a446c145b1435cfe12a1d4568aed0924a6a20 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.01e-04 | 178 | 39 | 3 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.09e-04 | 179 | 39 | 3 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.09e-04 | 179 | 39 | 3 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 179 | 39 | 3 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-04 | 179 | 39 | 3 | b07ebfd4157ae7436f275add78f2ac9ffc55f417 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.09e-04 | 179 | 39 | 3 | 040a7e916baaf81f44339dc721ab2afcd2c22388 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.18e-04 | 180 | 39 | 3 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 181 | 39 | 3 | 9bfd93cf053beaee806cacdffd7abef02f94aec6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 181 | 39 | 3 | 4a225d9a6d113396c6b1d0a839bb4ca9c339a260 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 181 | 39 | 3 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 181 | 39 | 3 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 5.26e-04 | 181 | 39 | 3 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.35e-04 | 182 | 39 | 3 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-04 | 183 | 39 | 3 | ab38264daddccdf5ffb75ff2210b27423eca6bc0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-04 | 183 | 39 | 3 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-04 | 183 | 39 | 3 | e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-04 | 183 | 39 | 3 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-04 | 183 | 39 | 3 | 263bfa1d8a7314bc3156c735c403c3bab8ea4dac | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-04 | 183 | 39 | 3 | a742c9a33f32058f9fb051733e3e736bc704d8e6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-04 | 183 | 39 | 3 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-04 | 183 | 39 | 3 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-04 | 184 | 39 | 3 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-04 | 184 | 39 | 3 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-04 | 185 | 39 | 3 | 03df43e9c2ce4ec24ffed8e4e2993f94ba951c8b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-04 | 185 | 39 | 3 | de2c24719946d5a37a982d816776cea7f3984c49 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-04 | 185 | 39 | 3 | dbdbd6593cd98550238519746bb45fbf0617550b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-04 | 186 | 39 | 3 | f6743d1f1d57d9d9a4581a88f156078a1da46816 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-04 | 186 | 39 | 3 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-04 | 186 | 39 | 3 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 5.69e-04 | 186 | 39 | 3 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-04 | 187 | 39 | 3 | 0ef82111b9049cc7ee78d64d240e1f10ab14d6b6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 187 | 39 | 3 | 8c69fd469df2915c56ede534cee3ef23d5f64ebf | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.78e-04 | 187 | 39 | 3 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 5.78e-04 | 187 | 39 | 3 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 187 | 39 | 3 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.78e-04 | 187 | 39 | 3 | a27aa97aa6508a3ffe92c2b6bb0511a95650a390 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.78e-04 | 187 | 39 | 3 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 5.87e-04 | 188 | 39 | 3 | e711c7a46d7cfa030ca2982eacc1dae5af5788dd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-04 | 188 | 39 | 3 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-04 | 188 | 39 | 3 | 0da6d6d3c28e9d99159b1a24a345a2250e8e1995 | |
| ToppCell | Control|World / Disease Group and Platelet Clusters | 5.87e-04 | 188 | 39 | 3 | f07654b215279abaf1c0882cdf41fbe31580a2ca | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-04 | 188 | 39 | 3 | 4e1b9880b61c0a21beda6ce5e2c3523fd6adb51c | |
| ToppCell | (1)_T_CD4|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.97e-04 | 189 | 39 | 3 | 2298a96c53c5bd767e17554c50379b2d1ad8b5b0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-04 | 189 | 39 | 3 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-04 | 189 | 39 | 3 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 5.97e-04 | 189 | 39 | 3 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-04 | 189 | 39 | 3 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | Control-PLT_3|World / Disease Group and Platelet Clusters | 5.97e-04 | 189 | 39 | 3 | f65c261fe25479e900d5ed1a0d25a9dec302a57b | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 5.97e-04 | 189 | 39 | 3 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-04 | 189 | 39 | 3 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 189 | 39 | 3 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-04 | 190 | 39 | 3 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-04 | 190 | 39 | 3 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-04 | 190 | 39 | 3 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-04 | 190 | 39 | 3 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.06e-04 | 190 | 39 | 3 | a28e14fff75c36b1a8634eaf3f305e3206fdc2ed | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.15e-04 | 191 | 39 | 3 | a4200717672e2358eb649eae2553f293b4fd8f7e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION | |
| Drug | Epothilone D | 1.55e-14 | 12 | 39 | 6 | DB01873 | |
| Drug | Epothilone B | 1.55e-14 | 12 | 39 | 6 | DB03010 | |
| Drug | Stylophorin | 9.82e-11 | 43 | 39 | 6 | CID000010147 | |
| Drug | bromocolchicine | 2.25e-10 | 21 | 39 | 5 | CID000161518 | |
| Drug | Ustiloxin A | 2.25e-10 | 21 | 39 | 5 | CID000164454 | |
| Drug | SRI-3072 | 2.25e-10 | 21 | 39 | 5 | CID000493469 | |
| Drug | colchifoline | 2.25e-10 | 21 | 39 | 5 | CID000100132 | |
| Drug | 3,4,5-trimethoxyacetophenone | 2.91e-10 | 22 | 39 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 2.91e-10 | 22 | 39 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 2.91e-10 | 22 | 39 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 2.91e-10 | 22 | 39 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 2.91e-10 | 22 | 39 | 5 | CID000023759 | |
| Drug | NSC-339672 | 2.91e-10 | 22 | 39 | 5 | CID000433930 | |
| Drug | IKP104 | 3.72e-10 | 23 | 39 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 3.72e-10 | 23 | 39 | 5 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 3.72e-10 | 23 | 39 | 5 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 3.72e-10 | 23 | 39 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 3.72e-10 | 23 | 39 | 5 | CID000129239 | |
| Drug | AC1L2P05 | 3.72e-10 | 23 | 39 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 3.72e-10 | 23 | 39 | 5 | CID000125548 | |
| Drug | NSC-373301 | 3.72e-10 | 23 | 39 | 5 | CID000341375 | |
| Drug | N-acetylcolchinol | 3.72e-10 | 23 | 39 | 5 | CID000097865 | |
| Drug | NSC355636 | 3.72e-10 | 23 | 39 | 5 | CID000100176 | |
| Drug | moscatilin | 4.69e-10 | 24 | 39 | 5 | CID000176096 | |
| Drug | parbendazole | 4.69e-10 | 24 | 39 | 5 | CID000026596 | |
| Drug | NSC-36768 | 4.69e-10 | 24 | 39 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 4.69e-10 | 24 | 39 | 5 | CID000014995 | |
| Drug | tropolone methyl ether | 4.69e-10 | 24 | 39 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 4.69e-10 | 24 | 39 | 5 | CID000330401 | |
| Drug | NABV | 4.69e-10 | 24 | 39 | 5 | CID000175959 | |
| Drug | colchicide | 4.69e-10 | 24 | 39 | 5 | CID000120712 | |
| Drug | AC1L4TG7 | 4.69e-10 | 24 | 39 | 5 | CID000163705 | |
| Drug | NBD-colcemid | 5.85e-10 | 25 | 39 | 5 | CID000130594 | |
| Drug | mpMap | 5.85e-10 | 25 | 39 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 5.85e-10 | 25 | 39 | 5 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 5.85e-10 | 25 | 39 | 5 | CID000043264 | |
| Drug | allocolchicine | 5.85e-10 | 25 | 39 | 5 | CID000196989 | |
| Drug | 1069C85 | 5.85e-10 | 25 | 39 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 5.85e-10 | 25 | 39 | 5 | CID006438440 | |
| Drug | CA1P | 5.85e-10 | 25 | 39 | 5 | CID006918545 | |
| Drug | peloruside A | 5.85e-10 | 25 | 39 | 5 | CID006918506 | |
| Drug | NSC142227 | 5.85e-10 | 25 | 39 | 5 | CID000073427 | |
| Drug | MDL 27048 | 5.85e-10 | 25 | 39 | 5 | CID006439188 | |
| Drug | NSC527981 | 7.24e-10 | 26 | 39 | 5 | CID000352796 | |
| Drug | NSC332029 | 7.24e-10 | 26 | 39 | 5 | CID000100073 | |
| Drug | indibulin | 7.24e-10 | 26 | 39 | 5 | CID000002929 | |
| Drug | pironetin | 7.24e-10 | 26 | 39 | 5 | CID006438891 | |
| Drug | isaxonine | 7.24e-10 | 26 | 39 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 8.87e-10 | 27 | 39 | 5 | CID000004862 | |
| Drug | NSC292222 | 8.87e-10 | 27 | 39 | 5 | CID000099957 | |
| Drug | dinitroanilines | 8.87e-10 | 27 | 39 | 5 | CID000136400 | |
| Drug | NSC D-669356 | 8.87e-10 | 27 | 39 | 5 | CID000178028 | |
| Drug | NSC 370147 | 1.08e-09 | 28 | 39 | 5 | CID000182762 | |
| Drug | NSC72302 | 1.08e-09 | 28 | 39 | 5 | CID000118078 | |
| Drug | AAGTP | 1.18e-09 | 64 | 39 | 6 | CID000656407 | |
| Drug | bp U | 1.30e-09 | 29 | 39 | 5 | CID000368697 | |
| Drug | Aids106696 | 1.30e-09 | 29 | 39 | 5 | CID006475933 | |
| Drug | ddGDP | 1.30e-09 | 29 | 39 | 5 | CID000134739 | |
| Drug | oxibendazole | 1.30e-09 | 29 | 39 | 5 | CID000004622 | |
| Drug | AC1NBBHE | 1.56e-09 | 30 | 39 | 5 | CID004490620 | |
| Drug | eleutherobin | 1.56e-09 | 30 | 39 | 5 | CID006918335 | |
| Drug | azatoxin | 1.56e-09 | 30 | 39 | 5 | CID000125383 | |
| Drug | NSC617668 | 1.56e-09 | 30 | 39 | 5 | CID000357989 | |
| Drug | citostal | 1.56e-09 | 30 | 39 | 5 | CID000018991 | |
| Drug | thiocolchicine | 1.56e-09 | 30 | 39 | 5 | CID000017648 | |
| Drug | tropone | 1.86e-09 | 31 | 39 | 5 | CID000010881 | |
| Drug | NSC609395 | 1.86e-09 | 31 | 39 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 1.86e-09 | 31 | 39 | 5 | CID000100524 | |
| Drug | AC7700 | 1.86e-09 | 31 | 39 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 1.86e-09 | 31 | 39 | 5 | CID000032851 | |
| Drug | AC1L3V8I | 1.86e-09 | 31 | 39 | 5 | CID000122777 | |
| Drug | NSC332598 | 1.86e-09 | 31 | 39 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.86e-09 | 31 | 39 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 2.20e-09 | 32 | 39 | 5 | CID000003583 | |
| Drug | E2-3,4-Q | 2.20e-09 | 32 | 39 | 5 | CID000067402 | |
| Drug | NSC153858 | 2.20e-09 | 32 | 39 | 5 | CID000547450 | |
| Drug | 2-demethylcolchicine | 2.20e-09 | 32 | 39 | 5 | CID000023757 | |
| Drug | CA4P | 2.59e-09 | 33 | 39 | 5 | CID000370232 | |
| Drug | taltobulin | 2.59e-09 | 33 | 39 | 5 | CID006918637 | |
| Drug | mebendazole | 2.59e-09 | 33 | 39 | 5 | CID000004030 | |
| Drug | triethyllead | 3.03e-09 | 34 | 39 | 5 | CID006328106 | |
| Drug | NSC376450 | 3.03e-09 | 34 | 39 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 3.03e-09 | 34 | 39 | 5 | CID000161091 | |
| Drug | discodermolide | 3.53e-09 | 35 | 39 | 5 | CID000643668 | |
| Drug | AC1O5Y0F | 4.73e-09 | 37 | 39 | 5 | CID006442852 | |
| Drug | DTAF | 4.73e-09 | 37 | 39 | 5 | CID000123934 | |
| Drug | albendazole | 4.73e-09 | 37 | 39 | 5 | CID000002082 | |
| Drug | baccatin III | 4.73e-09 | 37 | 39 | 5 | CID000065366 | |
| Drug | laulimalide | 5.44e-09 | 38 | 39 | 5 | CID006918457 | |
| Drug | gnoscopine | 5.44e-09 | 38 | 39 | 5 | CID000004544 | |
| Drug | colchiceine | 5.44e-09 | 38 | 39 | 5 | CID000010156 | |
| Drug | erianin | 6.23e-09 | 39 | 39 | 5 | CID000356759 | |
| Drug | Dolastatin 10 | 6.23e-09 | 39 | 39 | 5 | CID000100208 | |
| Drug | AC1L8GZ1 | 7.12e-09 | 40 | 39 | 5 | CID000381235 | |
| Drug | indanone | 8.10e-09 | 41 | 39 | 5 | CID000006735 | |
| Drug | amoebal | 8.10e-09 | 41 | 39 | 5 | CID000001985 | |
| Drug | lumicolchicine | 8.10e-09 | 41 | 39 | 5 | CID000072624 | |
| Drug | AC1L9CY0 | 1.04e-08 | 43 | 39 | 5 | CID000396644 | |
| Drug | ABT-751 | 1.17e-08 | 44 | 39 | 5 | CID003035714 | |
| Drug | A805480 | 1.17e-08 | 44 | 39 | 5 | CID000620368 | |
| Disease | polymicrogyria (implicated_via_orthology) | 2.13e-24 | 8 | 36 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | microlissencephaly (implicated_via_orthology) | 2.13e-24 | 8 | 36 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 2.13e-24 | 8 | 36 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 4.64e-18 | 27 | 36 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.30e-04 | 14 | 36 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | thrombocytopenia (is_implicated_in) | 4.98e-04 | 27 | 36 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | hepatitis C (is_implicated_in) | 5.36e-04 | 28 | 36 | 2 | DOID:1883 (is_implicated_in) | |
| Disease | Tinnitus | 5.36e-04 | 130 | 36 | 3 | HP_0000360 | |
| Disease | excessive daytime sleepiness measurement | 7.46e-04 | 33 | 36 | 2 | EFO_0007875 | |
| Disease | Thyroid preparation use measurement | 2.34e-03 | 217 | 36 | 3 | EFO_0009933 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.80e-03 | 75 | 36 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | Glioblastoma | 4.20e-03 | 79 | 36 | 2 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 4.74e-03 | 84 | 36 | 2 | C0334588 | |
| Disease | hypothyroidism | 4.98e-03 | 284 | 36 | 3 | EFO_0004705 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLWDPPNCLIKGYGG | 646 | Q9UKF5 | |
| PLGVCVGIGAWNYPF | 146 | P49189 | |
| GYLRLPGPGWSCLFS | 56 | Q9HB65 | |
| LGFLGYCPQENALWP | 1361 | Q8IUA7 | |
| GFALAPGPFDWPCFL | 176 | Q12887 | |
| LFLGPWPAASHGGKY | 21 | P30533 | |
| GWPLPKYLGSCGRFL | 231 | Q9H7Y0 | |
| GQWPYGRFLCKLIPS | 86 | Q16581 | |
| WTLQCQGPYGGKPVI | 341 | Q9Y620 | |
| ACGCPLYWKGPLFYG | 171 | Q9Y5P8 | |
| EWARGGVQLYPGPKC | 1571 | O75147 | |
| WKPGFDGGLPQRFCI | 961 | O60500 | |
| LIGGYYCDCIPGWKG | 441 | Q9Y219 | |
| YKGFPPKWSGRCGLG | 306 | Q9H9K5 | |
| LQYPGTWCFIGLGPP | 181 | P34995 | |
| WGKGCALPNRPGVYT | 251 | Q8NF86 | |
| QYGIIPWNAFPGKIC | 191 | Q13491 | |
| LQGGAVYLCPWGASP | 91 | P08648 | |
| GYLGLGVLPGKPQCW | 471 | Q9BSJ5 | |
| RCALGSWGYGKPFEP | 716 | Q8IXH8 | |
| CFNALGGLPGPYIKW | 76 | Q9BY32 | |
| NPIYSCKVFLGGVPW | 306 | Q9BZB8 | |
| VGPYVPLWLGCEAGF | 341 | Q9HAT8 | |
| GPYVPLWLGQEAGLC | 391 | Q8N2H9 | |
| CYKLWGPGLPNFFRA | 676 | P29590 | |
| GQLLKTWCGSPPYAA | 216 | Q9Y2K2 | |
| GPCLGFRKPKQPYQW | 106 | Q9UKU0 | |
| LQWVGSPCGLHGPYI | 6 | Q14865 | |
| WCPTGFKVGINYQPP | 346 | P0DPH8 | |
| PCIYFWGGLLPFGML | 6 | O15455 | |
| WCPTGFKVGINYQPP | 346 | P0DPH7 | |
| KGPAYCQRLWPGPLL | 411 | Q96DC7 | |
| GFIYQGSKNWIRPCP | 166 | O43548 | |
| WCPTGFKVGINYQPP | 346 | Q71U36 | |
| WCPTGFKVGINYQPP | 346 | Q6PEY2 | |
| WCPTGFKVGINYQPP | 346 | P68363 | |
| GPSFKICVGFLGPRW | 81 | Q6PDA7 | |
| WCPTGFKVGINYQPP | 346 | Q9BQE3 | |
| WCPTGFKVGINYQPP | 346 | Q9NY65 | |
| WCPTGFKVGINYQPP | 346 | P68366 |